Mice expressing GECIs in a cell type-specific manner can be subject to hypertension-inducing treatments (administration of AngII, or L-NAME), allowing exploration of calcium signaling changes in vasculature and organs such as the kidneys, in comparison to healthy control animals. The gene discussed is AGT; the disease is Hypertension.